Literature DB >> 26194073

Trends in the Diabetes Epidemic in Korea.

Kyoung Hwa Ha1, Dae Jung Kim2.   

Abstract

Diabetes mellitus is a leading cause of mortality and increased disability-adjusted life years worldwide. In Korea, the prevalence of diabetes increased from 8.6% to 11.0% in 2001 to 2013 and the prevalence of adult obesity, which is the most important risk factor of diabetes, increased from 29.2% to 31.8% during the same period. There has been a dramatic increase in the number of obese Koreans with diabetes in recent decades and the prevalence of diabetes in people aged 40 years and older also increased in 2001 to 2013. Nevertheless, the mean age at the first diagnosis of diabetes was very similar for men in 2005 and 2013, while the mean age for women decreased slightly. There is an inverse linear relationship between body mass index and age at the diagnosis of diabetes among those who are newly diagnosed. Accordingly, the prevalence of diabetes is increasingly shifting to younger individuals and those who are obese. Therefore, public efforts should focus on healthy lifestyle changes, primary prevention measures, screening for the early detection of diabetes, and long-term management.

Entities:  

Keywords:  Age; Diabetes mellitus; Epidemiology; Korea; National survey; Obesity; Prevalence

Year:  2015        PMID: 26194073      PMCID: PMC4508257          DOI: 10.3803/EnM.2015.30.2.142

Source DB:  PubMed          Journal:  Endocrinol Metab (Seoul)        ISSN: 2093-596X


INTRODUCTION

Diabetes mellitus is a leading cause of mortality and increased disability-adjusted life years (DALYs) worldwide. In 2010, an estimated 1.3 million diabetes-related deaths occurred worldwide, which was twice as many as occurred in 1990 [1]. Furthermore, the DALYs from diabetes increased by 30% during this same period from 380 per 1,000 persons to 523 per 1,000 persons [2]. Although the mortality rate of diabetes in Korea decreased from 25.0 per 100,000 persons in 2003 to 21.5 per 100,000 persons in 2013, diabetes was still ranked as the fifth most common cause of death in 2013 [3]. In addition to its association with mortality, diabetes, and diabetes-related chronic complications such as retinopathy, neuropathy, nephropathy, cardiovascular, and cerebrovascular diseases, peripheral artery occlusive diseases, and amputations are related to significant increases in medical costs [4].

PREVALENCE OF DIABETES AND OBESITY

Recently, the prevalence of diabetes has increased in conjunction with the incidence of obesity. According the Korea National Health and Nutrition Examination Survey (KNHANES) studies in 2001 to 2013, the age-standardized prevalence of diabetes among adults 30 years of age and older increased from 8.6% to 11.0% and the age-standardized prevalence of adult obesity, defined as a body mass index (BMI) of 25 kg/m2 or higher, increased from 29.2% to 31.8% [56]. During the same period, the rates of diabetes and obesity tended to increase among men, while among women the prevalence of diabetes increased but the prevalence of obesity decreased (Fig. 1).
Fig. 1

(A-C) Prevalence of diabetes and obesity among Korean adults aged ≥30 years in 2001 to 2013.

Studies have consistently reported an association between obesity and diabetes. In a large representative sample from the United States, the highest prevalence of diabetes was observed in subjects with a BMI ≥40 kg/m2 [7], and Menke et al. [8] found that changes in BMI over time are the greatest contributor to the increased prevalence of diabetes in this population. Eckel et al. [9] demonstrated that obesity is linked to diabetes through the increased production of adipokines and cytokines, reductions in adiponectin levels, altered ectopic fat deposition, and mitochondrial dysfunction. However, because not all obese individuals develop diabetes, the relationship between obesity and diabetes remains unclear. For example, the influence of abdominal obesity on the risk of diabetes was found to be more important than that of general obesity [10]. Given the striking parallel increases in the incidences of these two conditions, obesity is likely an important contributing factor to the manifestation of diabetes and the complications, mortality, and morbidity related to this disease [11]. In recent decades, there has been a dramatic increase in the number of obese people with diabetes in Korea. The average BMI of diabetic Korean patients increased from 21.9 kg/m2 in 1989 to 1990 to 24.8 kg/m2 in 2010 to 2012 [1213]. In 2013, 71.6% of men and 74.2% of women with diabetes were obese or overweight (Fig. 2, unpublished data).
Fig. 2

Distribution of obesity in diabetic (A) men and (B) women in the Korea National Health and Nutrition Examination Survey 2001 to 2013. We defined obesity using the following body mass index (BMI) categories: normal (BMI<23 kg/m2), overweight (23≤BMI<25 kg/m2), and obese (BMI≥25 kg/m2).

AGE-SPECIFIC TRENDS IN THE PREVALENCE OF DIABETES

National surveys conducted between 2001 and 2013 in Korea revealed age-related increases in the prevalence of diabetes in all age groups, except for those between 30 and 39 years of age [5]. Because Korea is a rapidly aging society, this increase was particularly evident in people aged 70 years and older; the rate of diabetes in this age group was 27.6% in 2013, approximately twice as high as in 2001 (Fig. 3). However, the mean age at first diagnosis of diabetes was very similar among men in 2005 (49.3 years) and 2013 (50.6 years), while the mean age among women decreased slightly from 56.4 to 55.3 years (Fig. 4, unpublished data). Thus, there is roughly a 5-year difference between men and women in terms of age at the first diagnosis of diabetes.
Fig. 3

Age-specific prevalence rates of diabetes among Koreans during 2001 to 2013.

Fig. 4

Age at the initial diagnosis of diabetes in the Korea National Health and Nutrition Examination Survey 2005 to 2013.

According to the Centers for Disease Control and Prevention in the United States, the mean and median ages at the first diagnosis of diabetes among American adults aged 18 years or older were 53.7 and 53.8 years in 1997 and 53.8 and 54.2 years in 2011 [14]. The median ages at diagnosis of diabetes were 53.6 years for men and 55.2 years for women in 2011 [14]. In Korea, the age at the diagnosis of diabetes is similar to that in the United States, but Korean men tend to develop diabetes about 3 years earlier than American men (unpublished data).

OBESITY AND AGE AT THE DIAGNOSIS OF DIABETES

The KNHANES 2013 revealed an inverse linear relationship between BMI and age at diagnosis of diabetes among newly diagnosed subjects (Fig. 5, unpublished data). It has been reported that obesity is independently associated with early onset diabetes [15] and the European Prospective Investigation into Cancer and Nutrition-Potsdam Study found that weight gain in early adulthood (25 to 40 years) is more strongly associated with the risk and earlier onset of diabetes than weight gain after the age of 40 years [16].
Fig. 5

Association of body mass index (BMI) and age at diagnosis in newly diagnosed subjects with diabetes in the Korea National Health and Nutrition Examination Survey 2013.

A number of studies have reported that the age at onset and duration of diabetes are associated with microvascular events, cardiovascular disease, and all-cause mortality. For example, Banerjee et al. [17] suggested that the duration of diabetes is an important determinant of ischemic stroke risk. Zoungas et al. [18] reported that diabetes duration is independently associated with the risk of macrovascular complications such as cardiovascular death, non-fatal myocardial infarctions or nonfatal strokes, microvascular complications such as nephropathy and retinopathy, and death from any cause. Additionally, a longer duration of diabetes is associated with serious diabetes-related long-term complications in midlife [19]. Wannamethee et al. [20] demonstrated that people who developed diabetes prior to 60 years of age had a risk of coronary heart disease that was approximately twice that of persons who were diagnosed with diabetes after age 60. Because the chronic worsening of hyperglycemia is generally associated with an insulin insufficiency in individuals with a longer duration of diabetes, it is difficult to determine the underlying mechanisms. This finding may have important public health and economic implications because individuals with diabetes tend to require sustained health services and often develop early complications during the period of highest productivity.

CONCLUSIONS

In conclusion, the prevalence of diabetes is increasingly shifting to younger individuals and obese people. As more people develop diabetes earlier and live longer, public efforts should focus on healthy lifestyle changes, primary prevention measures, screening for the early detection of diabetes, and long-term management. Following a diagnosis of diabetes, treatment measures should include intensive glycemic control to minimize the risk of microvascular and macrovascular complications. Because the treatment of obesity is an important intervention that can reduce the prevalence of diabetes, the management of obesity should be considered for obese people with diabetes.
  15 in total

1.  Obesity. A new paradigm for treating obesity and diabetes mellitus.

Authors:  André J Scheen; Nicolas Paquot
Journal:  Nat Rev Endocrinol       Date:  2015-01-27       Impact factor: 43.330

2.  Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.

Authors:  Anja Schienkiewitz; Matthias B Schulze; Kurt Hoffmann; Anja Kroke; Heiner Boeing
Journal:  Am J Clin Nutr       Date:  2006-08       Impact factor: 7.045

3.  Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study.

Authors:  Chirantan Banerjee; Yeseon P Moon; Myunghee C Paik; Tatjana Rundek; Consuelo Mora-McLaughlin; Julio R Vieira; Ralph L Sacco; Mitchell S V Elkind
Journal:  Stroke       Date:  2012-03-01       Impact factor: 7.914

4.  Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset.

Authors:  T A Hillier; K L Pedula
Journal:  Diabetes Care       Date:  2001-09       Impact factor: 19.112

5.  Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.

Authors:  Meda E Pavkov; Peter H Bennett; William C Knowler; Jonathan Krakoff; Maurice L Sievers; Robert G Nelson
Journal:  JAMA       Date:  2006-07-26       Impact factor: 56.272

6.  Associations between trends in race/ethnicity, aging, and body mass index with diabetes prevalence in the United States: a series of cross-sectional studies.

Authors:  Andy Menke; Keith F Rust; Judith Fradkin; Yiling J Cheng; Catherine C Cowie
Journal:  Ann Intern Med       Date:  2014-09-02       Impact factor: 25.391

7.  Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey, 1999-2006.

Authors:  Ninh T Nguyen; Xuan-Mai T Nguyen; John Lane; Ping Wang
Journal:  Obes Surg       Date:  2011-03       Impact factor: 4.129

8.  The epidemiology of diabetes in Korea.

Authors:  Dae Jung Kim
Journal:  Diabetes Metab J       Date:  2011-08-31       Impact factor: 5.376

9.  Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes.

Authors:  Sophia Zoungas; Mark Woodward; Qiang Li; Mark E Cooper; Pavel Hamet; Stephen Harrap; Simon Heller; Michel Marre; Anushka Patel; Neil Poulter; Bryan Williams; John Chalmers
Journal:  Diabetologia       Date:  2014-09-17       Impact factor: 10.122

10.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Christopher J L Murray; Theo Vos; Rafael Lozano; Mohsen Naghavi; Abraham D Flaxman; Catherine Michaud; Majid Ezzati; Kenji Shibuya; Joshua A Salomon; Safa Abdalla; Victor Aboyans; Jerry Abraham; Ilana Ackerman; Rakesh Aggarwal; Stephanie Y Ahn; Mohammed K Ali; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Adil N Bahalim; Suzanne Barker-Collo; Lope H Barrero; David H Bartels; Maria-Gloria Basáñez; Amanda Baxter; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Eduardo Bernabé; Kavi Bhalla; Bishal Bhandari; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; James A Black; Hannah Blencowe; Jed D Blore; Fiona Blyth; Ian Bolliger; Audrey Bonaventure; Soufiane Boufous; Rupert Bourne; Michel Boussinesq; Tasanee Braithwaite; Carol Brayne; Lisa Bridgett; Simon Brooker; Peter Brooks; Traolach S Brugha; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Geoffrey Buckle; Christine M Budke; Michael Burch; Peter Burney; Roy Burstein; Bianca Calabria; Benjamin Campbell; Charles E Canter; Hélène Carabin; Jonathan Carapetis; Loreto Carmona; Claudia Cella; Fiona Charlson; Honglei Chen; Andrew Tai-Ann Cheng; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Manu Dahiya; Nabila Dahodwala; James Damsere-Derry; Goodarz Danaei; Adrian Davis; Diego De Leo; Louisa Degenhardt; Robert Dellavalle; Allyne Delossantos; Julie Denenberg; Sarah Derrett; Don C Des Jarlais; Samath D Dharmaratne; Mukesh Dherani; Cesar Diaz-Torne; Helen Dolk; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Karen Edmond; Alexis Elbaz; Suad Eltahir Ali; Holly Erskine; Patricia J Erwin; Patricia Espindola; Stalin E Ewoigbokhan; Farshad Farzadfar; Valery Feigin; David T Felson; Alize Ferrari; Cleusa P Ferri; Eric M Fèvre; Mariel M Finucane; Seth Flaxman; Louise Flood; Kyle Foreman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Marlene Fransen; Michael K Freeman; Belinda J Gabbe; Sherine E Gabriel; Emmanuela Gakidou; Hammad A Ganatra; Bianca Garcia; Flavio Gaspari; Richard F Gillum; Gerhard Gmel; Diego Gonzalez-Medina; Richard Gosselin; Rebecca Grainger; Bridget Grant; Justina Groeger; Francis Guillemin; David Gunnell; Ramyani Gupta; Juanita Haagsma; Holly Hagan; Yara A Halasa; Wayne Hall; Diana Haring; Josep Maria Haro; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Hideki Higashi; Catherine Hill; Bruno Hoen; Howard Hoffman; Peter J Hotez; Damian Hoy; John J Huang; Sydney E Ibeanusi; Kathryn H Jacobsen; Spencer L James; Deborah Jarvis; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Jost B Jonas; Ganesan Karthikeyan; Nicholas Kassebaum; Norito Kawakami; Andre Keren; Jon-Paul Khoo; Charles H King; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Francine Laden; Ratilal Lalloo; Laura L Laslett; Tim Lathlean; Janet L Leasher; Yong Yi Lee; James Leigh; Daphna Levinson; Stephen S Lim; Elizabeth Limb; John Kent Lin; Michael Lipnick; Steven E Lipshultz; Wei Liu; Maria Loane; Summer Lockett Ohno; Ronan Lyons; Jacqueline Mabweijano; Michael F MacIntyre; Reza Malekzadeh; Leslie Mallinger; Sivabalan Manivannan; Wagner Marcenes; Lyn March; David J Margolis; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; Neil McGill; John McGrath; Maria Elena Medina-Mora; Michele Meltzer; George A Mensah; Tony R Merriman; Ana-Claire Meyer; Valeria Miglioli; Matthew Miller; Ted R Miller; Philip B Mitchell; Charles Mock; Ana Olga Mocumbi; Terrie E Moffitt; Ali A Mokdad; Lorenzo Monasta; Marcella Montico; Maziar Moradi-Lakeh; Andrew Moran; Lidia Morawska; Rintaro Mori; Michele E Murdoch; Michael K Mwaniki; Kovin Naidoo; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Paul K Nelson; Robert G Nelson; Michael C Nevitt; Charles R Newton; Sandra Nolte; Paul Norman; Rosana Norman; Martin O'Donnell; Simon O'Hanlon; Casey Olives; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Andrew Page; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Scott B Patten; Neil Pearce; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; Konrad Pesudovs; David Phillips; Michael R Phillips; Kelsey Pierce; Sébastien Pion; Guilherme V Polanczyk; Suzanne Polinder; C Arden Pope; Svetlana Popova; Esteban Porrini; Farshad Pourmalek; Martin Prince; Rachel L Pullan; Kapa D Ramaiah; Dharani Ranganathan; Homie Razavi; Mathilda Regan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Kathryn Richardson; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Felipe Rodriguez De Leòn; Luca Ronfani; Robin Room; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Sukanta Saha; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; David C Schwebel; James Graham Scott; Maria Segui-Gomez; Saeid Shahraz; Donald S Shepard; Hwashin Shin; Rupak Shivakoti; David Singh; Gitanjali M Singh; Jasvinder A Singh; Jessica Singleton; David A Sleet; Karen Sliwa; Emma Smith; Jennifer L Smith; Nicolas J C Stapelberg; Andrew Steer; Timothy Steiner; Wilma A Stolk; Lars Jacob Stovner; Christopher Sudfeld; Sana Syed; Giorgio Tamburlini; Mohammad Tavakkoli; Hugh R Taylor; Jennifer A Taylor; William J Taylor; Bernadette Thomas; W Murray Thomson; George D Thurston; Imad M Tleyjeh; Marcello Tonelli; Jeffrey A Towbin; Thomas Truelsen; Miltiadis K Tsilimbaris; Clotilde Ubeda; Eduardo A Undurraga; Marieke J van der Werf; Jim van Os; Monica S Vavilala; N Venketasubramanian; Mengru Wang; Wenzhi Wang; Kerrianne Watt; David J Weatherall; Martin A Weinstock; Robert Weintraub; Marc G Weisskopf; Myrna M Weissman; Richard A White; Harvey Whiteford; Natasha Wiebe; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Sean R M Williams; Emma Witt; Frederick Wolfe; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Anita K M Zaidi; Zhi-Jie Zheng; David Zonies; Alan D Lopez; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

View more
  43 in total

1.  GLP-1 receptor agonist on cardiovascular complications of diabetes mellitus.

Authors:  Fengjun Liu; Yanhua Kong
Journal:  Exp Ther Med       Date:  2020-01-20       Impact factor: 2.447

2.  Comparison of Open and Laparoscopic Gastrectomy in Elderly Patients.

Authors:  Su Mi Kim; Ho Geun Youn; Ji Yeong An; Yoon Young Choi; Sung Hoon Noh; Seung Jong Oh; Tae Sung Sohn; Sung Kim
Journal:  J Gastrointest Surg       Date:  2018-03-16       Impact factor: 3.452

3.  Social Networking Services-Based Communicative Care for Patients with Diabetes Mellitus in Korea.

Authors:  Hun-Sung Kim; Yoo Jin Jeong; Sun Jung Baik; So Jung Yang; Tong Min Kim; Hyunah Kim; Hyunyong Lee; Seung-Hwan Lee; Jae Hyoung Cho; In-Young Choi; Kun-Ho Yoon
Journal:  Appl Clin Inform       Date:  2016-09-28       Impact factor: 2.342

Review 4.  Diabetes in Asians.

Authors:  Eun Jung Rhee
Journal:  Endocrinol Metab (Seoul)       Date:  2015-09

5.  Association of Waist-Height Ratio with Diabetes Risk: A 4-Year Longitudinal Retrospective Study.

Authors:  Yoon Jeong Son; Jihyun Kim; Hye Jeong Park; Se Eun Park; Cheol Young Park; Won Young Lee; Ki Won Oh; Sung Woo Park; Eun Jung Rhee
Journal:  Endocrinol Metab (Seoul)       Date:  2016-03

Review 6.  Recent Advances in Diagnostic Strategies for Diabetic Peripheral Neuropathy.

Authors:  Jong Chul Won; Tae Sun Park
Journal:  Endocrinol Metab (Seoul)       Date:  2016-05-27

Review 7.  Health Performance and Challenges in Korea: a Review of the Global Burden of Disease Study 2013.

Authors:  Yo Han Lee; Seok Jun Yoon; Arim Kim; Hyeyoung Seo; Seulki Ko
Journal:  J Korean Med Sci       Date:  2016-11       Impact factor: 2.153

Review 8.  Current status of managing diabetes mellitus in Korea.

Authors:  Kyoung Hwa Ha; Dae Jung Kim
Journal:  Korean J Intern Med       Date:  2016-09-01       Impact factor: 2.884

9.  Letter: Characterization of Patients with Type 2 Diabetes according to Body Mass Index: Korea National Health and Nutrition Examination Survey from 2007 to 2011 (Endocrinol Metab 2015;30:514-21, Dong-Hwa Lee et al.).

Authors:  Eun Hee Cho
Journal:  Endocrinol Metab (Seoul)       Date:  2016-06

10.  Mortality and causes of death in a national sample of type 2 diabetic patients in Korea from 2002 to 2013.

Authors:  Yu Mi Kang; Ye-Jee Kim; Joong-Yeol Park; Woo Je Lee; Chang Hee Jung
Journal:  Cardiovasc Diabetol       Date:  2016-09-13       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.